Switzerland, as one of the leading global biotech hubs, was well positioned to facilitate international collaborations and develop solutions to combat the Covid-19...
The rollout of Johnson & Johnson’s Covid-19 vaccine could be resumed starting Apr. 23, Anthony Fauci, the top US infectious-disease expert and chief advisor to US...
The Italian government has held talks with several pharmaceutical companies, including Moderna, Novartis, CureVac and Italy’s ReiThera, about producing mRNA-based Covid...
US laboratory equipment maker Thermo Fisher Scientific has agreed to buy compatriot firm PPD, a contract research company for the pharma and biotech industry, for $17.4...
Activist hedge fund Elliott Management, also known as Elliott Associates or Elliott Advisers, has a new target – GlaxoSmithKline (GSK). Over the past decade, the fund has...
In partnership with the Singapore Economic Development Board (EDB), French drugmaker Sanofi is planning to invest more than €400 million to create what it said is a...
Johnson & Johnson has joined AstraZeneca in the negative spotlight, giving the latter some likely welcome relief. After studying a spate of usually rare blood-clotting...
Oxy Low Carbon Ventures (OLCV), a subsidiary of US-headquartered multinational energy company Occidental, and bio-engineering start-up Cemvita Factory plan to build and...
Under an expanded agreement, US contract manufacturer Catalent is dedicating a new high-speed vial filling line at its Bloomington, Indiana, biologics facility to the...
With the backing of the US government, Johnson & Johnson has taken over “full responsibility" for manufacturing at the Bayview plant operated by its Baltimore, Maryland...